BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 5, 2011
View Archived Issues
Creabilis Raises $20M in Series B to Advance Psoriasis Drug
Creabilis S.A. raised €15 million (US$20 million) in a Series B round to advance a pipeline of three compounds in development for dermatology, inflammation and pain indications. (BioWorld International)
Read More
European Biomedical Research Lags U.S. in Quality, Spending
Read More
Proposed Leukemia Therapy Acts Through Epigenetics
Read More
Galapagos Bags Potential $346M Cancer R&D Deal with Servier
Read More
Prosonix Brings in £11.4M to Back Smart Particle Technology
Read More
Lundbeck Gets Dibs on Proximagen CNS Products
Read More
$54M EC Vaccine Research Initiative to Kick Off in Siena
Read More
Other News To Note
Read More